August 7, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Todd Dickinson, President & CEO, Stellaromics
In this Q&A, Dickinson explains why conventional spatial platforms lose critical biological information by cutting tissue too thin, how its Pyxa® platform preserves native tissue architecture in sections up to 100 microns thick, and what that means for drug discovery, tumor biology, and patient care. More

Press Releases

  • FDA: Approves New Engineered Viral Immunotherapy for Patients With Treatment-Resistant Advanced Melanoma More
  • Northwest Biotherapeutics: MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company More
  • TransThera Sciences: Yochanra, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China More More*

Financial News


  • Biopharma Therapeutics and Platforms IPO Activity, Follow-ons and PIPEs – Q2 2026 Review More
  • Cartesian Therapeutic: New Employment Inducement Grants More
  • LSN: Hot Investor Mandates (Updated 8/4) More
  • More on Emergent BioSolutions Laying Off Dozens, Shedding Real Estate as Narcan Competition Strains Profits More* More* More
  • NextCure: Business Update and Second Quarter 2026 Financial Results More
  • Senseonics: Second Quarter 2026 Financial Results More

Media/Misc Coverage

  • Big4Bio CEO Weekly Q&A: Todd Dickinson, President & CEO, Stellaromics More
  • BioPharmGuy News: Mega Merger Mirage, Cash for Dash, Culture Issues, Re-Petes More
  • Exclusive: FDA Outlines Expedited IND Pilot Plans, Seeking to Pick Up to 10 Programs by Year-End More*
  • Polsinelli: Supporting Life Sciences From Formation to Exit More
  • Subscribe to LifeSci Startup for Updates on US Startups More
Cyprotex - An Evotec Company | Your trusted ADME-Tox partner. Discovery Bioanalysis. Tailored for the molecules that matter most. 1. Peptide therapeutics, 2. Endogenous biomarkers, 3. Complex small molecules. Learn more >

Career Moves

Telling Your Science Story to Investors
Learn More  →
  • ICYMI: Atossa Therapeutics Founder to Be Selected as NIAID Director — Report More*
  • ICYMI: Over 1/3 Stay in Biopharma Jobs for Health Insurance, Poll Finds More
  • Jennifer Taubert Announces Retirement From J&J; Takeda’s Global TYK2 Leader Exits More*
  • OPPORTUNITY: Chief Scientific Officer, Manassas, VA More
  • OPPORTUNITY: President, PA More
  • OPPORTUNITY: Vice President, Global BD, Remote More
  • Slone Partners: Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx More
  • Slone Partners: Places Farhad Ghavami as Chief Executive Officer at SeqCenter More
  • Slone Partners: The Convergence of MedTech and Digital Health - How New Hybrid Devices Are Reshaping Care Delivery and Leadership Profiles More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: Capital Region Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

Capital Region Sponsors



Follow us


Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:Capital Region, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.